Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 13, 2003. The report is a notification of a change in directors' interests rather than a comprehensive financial statement.
Key Financial Metrics
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is the share price of £12.47 per Ordinary Share, which was the price paid for shares acquired on January 10, 2003.
Material Changes
The material change reported is an increase in the shareholding of Director Mr. J D Coombe. This change resulted from the purchase of shares through the Company's ShareReward Plan.
Management Commentary and Unusual Items
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this document. The filing strictly details the mechanics of the share acquisition under the partnership and matching elements of the ShareReward Plan.
Key Facts for Investor Verification
- Director: Mr. J D Coombe.
- Transaction Date: January 10, 2003.
- Share Price: £12.47 per share.
- Shares Acquired: 10 shares via personal contribution and 10 shares via company matching contribution.
- Plan Details: The transaction occurred under the ShareReward Plan entered into on October 5, 2001.